2,6-bis(1H-1,2,3-triazol-4-yl)pyridine, >98.0%(HPLC), 200mg

(butan-2-yl)[(2,4-dimethoxyphenyl)methyl]amine, 95.0%, 10g

3-Amino-5-nitrobenzeneboronic acid pinacol ester, 95.0%, 250mg

N-(tert-Butoxycarbonyl)-D-threonine Methyl Ester, 98%, 1g

1-methyl-1H-pyrrole-3-carbaldehyde, 95.0%, 5g

3-BROMO-5-FLUOROPICOLINALDEHYDE, 95.0%, 1g

Recipiente de evaporación ROTILABO® con fondo plano, 90 ml, 10 Unidad(es)

n-Octane, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

4,4'-(Ethyne-1,2-diyl)dibenzaldehyde, 98%, 100mg

(6-Morpholinopyridin-3-yl)boronic acid, 95.0%, 25g

6-Chloro-1H-pyrrolo[3,2-c]pyridin-2(3H)-one, 95.0%, 5g

2-Acetylamino-thiazole-5-sulfonyl chloride, 95.0%, 1g

tert-Butyl (2-chloro-5-(trifluoromethyl)pyridin-3-yl)carbamate, 97%, 1g